Monovisc vs Durolane – Finding The Best OA Treatment

Last Updated On: October 1, 2024

Recent studies have shown a significant increase in the variety of osteoarthritis (OA) treatments available between 2022 and 2024. These range from non-pharmacological approaches like lifestyle changes to advanced pharmacological therapies like intra-articular hyaluronic acid injections.

Among these advanced treatments, Monovisc and Durolane stand out as popular options. Both are hyaluronic acid injections aimed at relieving joint pain and improving mobility. While Monovisc offers a convenient single-injection solution, Durolane features a high-concentration formula for extended relief. Understanding their differences can help you determine which option is best suited to your needs.

In this article, we will compare Monovisc and Durolane and explore their benefits, application processes, and effectiveness.

Key Takeaways

• Osteoarthritis (OA) is a common joint condition characterized by the gradual breakdown of cartilage, leading to pain, stiffness, and reduced mobility. Effective treatments range from non-pharmacological approaches like lifestyle changes to advanced pharmacological therapies such as intra-articular hyaluronic acid injections.
• Monovisc and Durolane are popular hyaluronic acid injections that relieve joint pain and improve mobility. Monovisc offers a convenient single-injection solution, while Durolane features a high-concentration formula for extended relief.
• Monovisc contains 4 mL of hyaluronic acid and provides targeted relief by restoring the lubrication within the knee joint. The single-injection approach of Monovisc makes it a convenient solution, and the effects typically last up to six months.
• Durolane contains 3 mL of hyaluronic acid and delivers sustained relief from osteoarthritis symptoms. The effects can last up to six months, making Durolane a popular choice for those seeking a convenient, lasting solution for osteoarthritis pain management.

About: Operating since 2016, Med Supply Solutions is known for being one of the industry’s top and trusted suppliers of cosmetic and viscosupplementation products. If you’re looking to buy Monovisc online, contact our sales department for more information.

MONOVISC®

SODIUM HYALURONATE

$349.00

Tier pricing

Save 2.87%

3 or more

$339.00 each

Save 4.3%

11 or more

$334.00 each

Save 5.73%

21 or more

$329.00 each

Understanding Osteoarthritis and Treatment Options

Osteoarthritis (OA) is a common joint condition characterized by the gradual breakdown of cartilage, leading to pain, stiffness, and reduced mobility. As the cartilage wears away, the bones may begin to rub directly against each other, resulting in increased discomfort and inflammation. This condition can affect daily activities, making it difficult for individuals to maintain their normal routines and quality of life.

Finding the right treatment for osteoarthritis is crucial for managing symptoms and preventing further joint damage. Effective treatments range from physical therapy and lifestyle modifications—such as exercise and weight management—to medications like nonsteroidal anti-inflammatory drugs (NSAIDs), which help reduce pain and inflammation.

For more advanced cases, injections like hyaluronic acid-based treatments, such as Monovisc and Durolane, can provide significant relief by lubricating the joint and reducing pain. An early diagnosis and a tailored treatment plan are essential for managing osteoarthritis effectively, minimizing pain, and enhancing overall mobility.

Monovisc

Monovisc is a leading injectable treatment designed to alleviate osteoarthritis (OA) pain, particularly in the knee. It contains 4 mL of hyaluronic acid (HA), miming the natural synovial fluid found in healthy joints. This high concentration of HA acts as both a lubricant and shock absorber, making it easier for patients to manage everyday activities and improving overall joint comfort.

Monovisc provides targeted relief by restoring the lubrication within the knee joint. This enhanced lubrication helps reduce friction between bones, effectively diminishing pain and inflammation. The single-injection approach of Monovisc makes it a convenient solution, as it requires only one dose to provide significant, long-lasting relief compared to multi-injection therapies.

This treatment is highly effective in managing OA symptoms, with many patients reporting reduced pain and improved mobility following treatment. The effects typically last up to six months, providing extended relief with minimal intervention. 

Recommended Dosage and Administration Schedule

The recommended dosage for Monovisc is a single 4 mL injection administered directly into the knee joint by a healthcare professional. This approach allows for effective pain relief without needing multiple treatments over a short period. Key points for administration include:

• Single Injection: Monovisc provides relief with just one injection delivered into the knee joint.
• Duration of Relief: Patients often experience significant pain reduction and improved joint function for up to six months.
• Procedure: The injection is given in a medical office or clinic. Before administering it, healthcare providers ensure the area is properly cleaned to minimize the risk of infection.
• Minimal Follow-Ups: Most patients do not need another injection for at least half a year, reducing the need for frequent medical visits.

Durolane

Durolane is a single-injection treatment designed to relieve osteoarthritis pain, particularly in the knee. It contains 3 mL of hyaluronic acid (HA), miming the body’s natural joint fluid, offering lubrication and shock absorption. This treatment is ideal for individuals seeking quick relief and improved joint function, enhancing quality of life and potentially delaying knee replacement surgery.

Durolane delivers hyaluronic acid directly into the affected joint. This acid acts as a lubricant and reduces bone friction, thereby alleviating pain and stiffness. The 60–75 mg of HA in Durolane is highly resistant to breakdown, which helps it provide sustained relief from osteoarthritis symptoms.

The effects can last up to six months, allowing patients to carry out daily activities more easily and comfortably. This extended duration of relief makes Durolane a popular choice for those seeking a convenient, lasting solution for osteoarthritis pain management.

Recommended Dosage and Administration Schedule

Durolane is administered as a single 3 mL injection for pain relief. Healthcare professionals should follow these steps to ensure safe and effective administration:

• Patient Assessment: To ensure safety, a thorough review of the patient’s medical history is essential before administering Durolane.
• Preparation: Clean the skin around the injection site thoroughly to prevent infection.
• Injection Procedure: Use a thin needle to inject 3mL of Durolane directly into the affected joint.
• Post-Injection Care: Advise the patient to rest the joint and avoid heavy activities immediately after the injection. Monitoring for side effects, such as swelling or pain around the injection site, is crucial to ensure patient safety.

Comparing Patient Reviews and Experiences

Patients have shared their experiences with Monovisc and Durolane, giving us insight into satisfaction and outcomes. Their stories shed light on which treatments, such as Monovisc vs. Euflexxa or Synvisc, might best work for OA pain types.

On Monovisc

• Tess: ”My knee ached pretty badly the day of the injection and that night. But it’s been over 6 months of pretty effective pain relief, so I’m pleased with Monovisc. Just scheduled my 2nd injection! Haven’t felt this good in years!”

On Durolane

• Nadia: “I had the Durolane + steroids injection 5 days ago injected into both knees. I felt relief immediately and had no problems. I have been without pain since then. I can walk, stand, and sleep much better and feel amazing. I am thrilled with the results of this injection and hope they last long.”

The choice between them might come down to specific factors like the HA quantity or injection volume preferences.

Making an Informed Decision

When deciding between Monovisc and Durolane for managing osteoarthritis (OA), several key factors should be considered to determine which treatment best suits your needs:

• Dosage Requirements: Monovisc requires a 4 mL injection, while Durolane uses 3 mL. This difference may affect patient comfort and overall treatment preference.
• Duration of Effects: Both Monovisc and Durolane offer pain and stiffness relief for up to six months, reducing the need for frequent doctor visits.
• Hyaluronic Acid (HA) Quantity: Monovisc contains more hyaluronic acid than Durolane, which contains 60–75 mg. The amount of HA may impact joint lubrication and overall effectiveness.
• Patient Experiences: Individual preferences may vary based on personal relief and side effect experiences. It is important to consider past treatments and how well they worked for each case.
• FDA Approval: Checking the FDA approval status is important, as it provides insight into the safety and efficacy of the treatment based on thorough evaluations. Both Monovisc and Durolane are approved for their specific use, reflecting their safety for patients.
• Single-Injection Convenience: Monovisc and Durolane offer the convenience of a single injection, making them appealing compared to multi-session treatments.
• Efficacy: Both treatments are equally effective, but the choice may depend on individual factors such as prior response to similar treatments and specific health conditions.

Conclusion

Choosing between Monovisc and Durolane for osteoarthritis treatment depends on your needs and preferences. Both options effectively reduce joint pain and improve mobility, each offering unique benefits. Consulting a healthcare professional is essential to determining the most suitable treatment for your condition. This ensures a personalized approach for the best possible outcome.

FAQs

1. What side effects are associated with Monovisc?

Monovisc may cause side effects, which can vary based on individual health conditions and responses to the treatment.

2. Does the FDA approve Monovisc?

Monovisc has received FDA approval as an effective treatment option for osteoarthritis.

3. How long do the effects of Monovisc typically last?

The effects of Monovisc generally last up to six months after a single injection, relieving osteoarthritis symptoms and improving joint function during this period. Individual results may vary based on patient-specific factors and the severity of the condition.

References

Pozzuoli A, Belluzzi E, Ruggieri P. Editorial: New trends in osteoarthritis treatment. Frontiers in Medicine. 2024;11. doi:10.3389/fmed.2024.1372052

University of Adelaide. Osteoarthritis Breakthrough: New Research Shows The Condition May Be Treatable and Reversible. SciTechDaily. Published November 11, 2023. https://scitechdaily.com/osteoarthritis-breakthrough-new-research-shows-that-the-condition-may-be-treatable-and-reversible/ 

Win Min Oo, Hunter DJ. Intra-articular Therapies for Knee Osteoarthritis: Current Update. Current Treatment Options in Rheumatology. 2023;9(3):99-119. doi:https://doi.org/10.1007/s40674-023-00207-x